These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 16185664)

  • 1. Sildenafil potentiates nitric oxide mediated inhibition of human platelet aggregation.
    Gudmundsdóttir IJ; McRobbie SJ; Robinson SD; Newby DE; Megson IL
    Biochem Biophys Res Commun; 2005 Nov; 337(1):382-5. PubMed ID: 16185664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of Sildenafil on human platelet secretory function is controlled by a complex interplay between phosphodiesterases 2, 3 and 5.
    Dunkern TR; Hatzelmann A
    Cell Signal; 2005 Mar; 17(3):331-9. PubMed ID: 15567064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relaxation and cyclic GMP levels in response to sildenafil in human pulmonary arteries from donors.
    Mauricio MD; Segarra G; Medina P; Aldasoro M; Martínez-León JB; Vila JM
    Eur J Pharmacol; 2006 Jan; 530(3):259-62. PubMed ID: 16380114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celecoxib dilates guinea-pig coronaries and rat aortic rings and amplifies NO/cGMP signaling by PDE5 inhibition.
    Klein T; Eltze M; Grebe T; Hatzelmann A; Kömhoff M
    Cardiovasc Res; 2007 Jul; 75(2):390-7. PubMed ID: 17383621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
    Sogo N; Magid KS; Shaw CA; Webb DJ; Megson IL
    Biochem Biophys Res Commun; 2000 Dec; 279(2):412-9. PubMed ID: 11118301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sildenafil inhibits phosphodiesterase type 5 in human clitoral corpus cavernosum smooth muscle.
    Park K; Moreland RB; Goldstein I; Atala A; Traish A
    Biochem Biophys Res Commun; 1998 Aug; 249(3):612-7. PubMed ID: 9731184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postnatal maturation of phosphodiesterase 5 (PDE5) in piglet pulmonary arteries: activity, expression, effects of PDE5 inhibitors, and role of the nitric oxide/cyclic GMP pathway.
    Moreno L; Losada B; Cogolludo Al; Lodi F; Lugnier C; Villamor E; Moro M; Tamargo J; Pérez-Vizcaíno F
    Pediatr Res; 2004 Oct; 56(4):563-70. PubMed ID: 15295092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of nitric oxide/cyclic GMP pathway in regulating spontaneous excitations in detrusor smooth muscle of the guinea-pig bladder.
    Yanai Y; Hashitani H; Hayase M; Sasaki S; Suzuki H; Kohri K
    Neurourol Urodyn; 2008; 27(5):446-53. PubMed ID: 17929303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sildenafil (Viagra) evokes retinal arteriolar dilation: dual pathways via NOS activation and phosphodiesterase inhibition.
    Yuan Z; Hein TW; Rosa RH; Kuo L
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):720-5. PubMed ID: 18235020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The selective PDE5 inhibitor, sildenafil, improves object memory in Swiss mice and increases cGMP levels in hippocampal slices.
    Rutten K; Vente JD; Sik A; Ittersum MM; Prickaerts J; Blokland A
    Behav Brain Res; 2005 Oct; 164(1):11-6. PubMed ID: 16076505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation.
    Blount MA; Beasley A; Zoraghi R; Sekhar KR; Bessay EP; Francis SH; Corbin JD
    Mol Pharmacol; 2004 Jul; 66(1):144-52. PubMed ID: 15213306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.
    Gordge MP; Hothersall JS; Noronha-Dutra AA
    Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats.
    Ferreira-Melo SE; Yugar-Toledo JC; Coelho OR; De Luca IM; Tanus-Santos JE; Hyslop S; Irigoyen MC; Moreno H
    Eur J Pharmacol; 2006 Aug; 542(1-3):141-7. PubMed ID: 16806160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells.
    Wharton J; Strange JW; Møller GM; Growcott EJ; Ren X; Franklyn AP; Phillips SC; Wilkins MR
    Am J Respir Crit Care Med; 2005 Jul; 172(1):105-13. PubMed ID: 15817798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinergic-NO-cGMP mediation of sildenafil-induced antinociception.
    Patil CS; Jain NK; Singh VP; Kulkarni SK
    Indian J Exp Biol; 2004 Apr; 42(4):361-7. PubMed ID: 15088685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of action of PDE5 inhibition in erectile dysfunction.
    Corbin JD
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S4-7. PubMed ID: 15224127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cyclic GMP-specific phosphodiesterase inhibitor, sildenafil, stimulates human sperm motility and capacitation but not acrosome reaction.
    Lefièvre L; De Lamirande E; Gagnon C
    J Androl; 2000; 21(6):929-37. PubMed ID: 11105920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of phosphodiesterase inhibition on cortical spreading depression and associated changes in extracellular cyclic GMP.
    Wang M; Urenjak J; Fedele E; Obrenovitch TP
    Biochem Pharmacol; 2004 Apr; 67(8):1619-27. PubMed ID: 15041479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipyridamole synergizes with nitric oxide to prolong inhibition of thrombin-induced platelet shape change.
    Jensen BO; Kleppe R; Kopperud R; Nygaard G; Døskeland SO; Holmsen H; Selheim F
    Platelets; 2011; 22(1):8-19. PubMed ID: 20958117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]sildenafil binding to phosphodiesterase-5 is specific, kinetically heterogeneous, and stimulated by cGMP.
    Corbin JD; Blount MA; Weeks JL; Beasley A; Kuhn KP; Ho YS; Saidi LF; Hurley JH; Kotera J; Francis SH
    Mol Pharmacol; 2003 Jun; 63(6):1364-72. PubMed ID: 12761347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.